Youssef M.K. Farag

746 total citations
20 papers, 140 citations indexed

About

Youssef M.K. Farag is a scholar working on Hematology, Nephrology and Genetics. According to data from OpenAlex, Youssef M.K. Farag has authored 20 papers receiving a total of 140 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 7 papers in Nephrology and 7 papers in Genetics. Recurrent topics in Youssef M.K. Farag's work include Erythropoietin and Anemia Treatment (11 papers), Hemoglobinopathies and Related Disorders (7 papers) and Iron Metabolism and Disorders (7 papers). Youssef M.K. Farag is often cited by papers focused on Erythropoietin and Anemia Treatment (11 papers), Hemoglobinopathies and Related Disorders (7 papers) and Iron Metabolism and Disorders (7 papers). Youssef M.K. Farag collaborates with scholars based in United States, Germany and Canada. Youssef M.K. Farag's co-authors include Wei Luo, Dennis Vargo, Zeeshan Khawaja, Masaomi Nangaku, Emil M. deGoma, Kai‐Uwe Eckardt, Elena Blasco‐Colmenares, Glenn M. Chertow, Di Zhao and Mark J. Koury and has published in prestigious journals such as Journal of the American Society of Nephrology, Journal of the American College of Surgeons and Clinical Journal of the American Society of Nephrology.

In The Last Decade

Youssef M.K. Farag

16 papers receiving 136 citations

Peers

Youssef M.K. Farag
Tara DiMino United States
B. Ehmer Germany
Karen L. Onions United Kingdom
Raashda A. Sulaiman Saudi Arabia
Magdalene M. George United States
Matthias Wörn Germany
Shivinder Jolly United Kingdom
Ashley E. Benson United States
Frank Joseph United Kingdom
A Calafiore Italy
Tara DiMino United States
Youssef M.K. Farag
Citations per year, relative to Youssef M.K. Farag Youssef M.K. Farag (= 1×) peers Tara DiMino

Countries citing papers authored by Youssef M.K. Farag

Since Specialization
Citations

This map shows the geographic impact of Youssef M.K. Farag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youssef M.K. Farag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youssef M.K. Farag more than expected).

Fields of papers citing papers by Youssef M.K. Farag

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youssef M.K. Farag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youssef M.K. Farag. The network helps show where Youssef M.K. Farag may publish in the future.

Co-authorship network of co-authors of Youssef M.K. Farag

This figure shows the co-authorship network connecting the top 25 collaborators of Youssef M.K. Farag. A scholar is included among the top collaborators of Youssef M.K. Farag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youssef M.K. Farag. Youssef M.K. Farag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Singh, Ajay, Stefan D. Anker, Peter Rossing, et al.. (2025). A FIDELITY Analysis on Finerenone With SGLT-2i and GLP-1RA in CKD. Kidney International Reports. 11(3). 103704–103704.
2.
Farag, Youssef M.K., et al.. (2025). Global Perspective on Kidney Transplantation in Egypt. Kidney360. 6(12). 2251–2253.
3.
James, Glen, Stefan D. Anker, Bertram Pitt, et al.. (2025). Finerenone Efficacy in Patients with Chronic Kidney Disease, Type 2 Diabetes, and Anemia in FIDELITY. JACC Advances. 4(2). 101524–101524.
4.
Claggett, Brian, Victoria Arthur, Kunihiro Matsushita, et al.. (2024). Plasma Ferritin Levels, Incident Heart Failure, and Cardiac Structure and Function. JACC Heart Failure. 12(3). 539–548. 2 indexed citations
5.
Farag, Youssef M.K., et al.. (2024). Predictive Value of Clinical, CSF and Vessel Wall MRI Variables in Diagnosing Primary Angiitis of the CNS. Neurology Clinical Practice. 14(4). e200321–e200321. 1 indexed citations
6.
Blasco‐Colmenares, Elena, Youssef M.K. Farag, Di Zhao, Eliseo Güallar, & Fredric O. Finkelstein. (2024). Anemia, CKD, and Cognitive Function: The National Health and Nutrition Examination Survey. Kidney360. 5(6). 895–899. 3 indexed citations
7.
Farag, Youssef M.K., et al.. (2024). Impact of Preoperative Weight Loss on 30-Day Complication Rate after Bariatric Surgery. Journal of the American College of Surgeons. 238(6). 993–999. 1 indexed citations
8.
Singh, Ajay, Youssef M.K. Farag, Zihe Zheng, & George L. Bakris. (2024). Clinical trial designs of emerging therapies for diabetic kidney disease (DKD). Postgraduate Medicine. 136(6). 585–593. 3 indexed citations
9.
Whitlock, Reid, Silvia J. Leon, Nicole Askin, et al.. (2023). The association between dual RAAS inhibition and risk of acute kidney injury and hyperkalemia in patients with diabetic kidney disease: a systematic review and meta-analysis. Nephrology Dialysis Transplantation. 38(11). 2503–2516. 17 indexed citations
10.
Farag, Youssef M.K., et al.. (2023). Association of Bioimpedance Parameters with Increases in Blood Pressure during Hemodialysis. Clinical Journal of the American Society of Nephrology. 19(3). 329–335. 1 indexed citations
11.
Farag, Youssef M.K., et al.. (2023). Effect of Anemia on Physical Function and Physical Activity in CKD: The National Health and Nutrition Examination Survey, 1999–2016. Kidney360. 4(9). e1212–e1222. 6 indexed citations
12.
Farag, Youssef M.K., et al.. (2022). Global Dialysis Perspective: Egypt. Kidney360. 3(7). 1263–1268. 21 indexed citations
13.
Koury, Mark J., Rajiv Agarwal, Glenn M. Chertow, et al.. (2022). Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease. American Journal of Hematology. 97(9). 1178–1188. 14 indexed citations
14.
Winkelmayer­, Wolfgang C., Steven Fishbane, James A. Tumlin, et al.. (2021). Iron-Related Outcomes in Patients with Dialysis-Dependent CKD Randomized to Vadadustat vs. Darbepoetin Alfa. Journal of the American Society of Nephrology. 32(10S). 182–182. 1 indexed citations
15.
Pérgola, Pablo E., Diogo Belo, Paul Crawford, et al.. (2021). Ferric Citrate Dosing in Iron Deficiency Anemia in Nondialysis-Dependent Chronic Kidney Disease. American Journal of Nephrology. 52(7). 572–581. 2 indexed citations
16.
Koury, Mark J., Pablo E. Pérgola, Prabir Roy‐Chaudhury, et al.. (2021). Iron-Related Outcomes in Patients with Non-Dialysis-Dependent CKD Randomized to Vadadustat vs. Darbepoetin Alfa. Journal of the American Society of Nephrology. 32(10S). 190–190. 1 indexed citations
17.
Winkelmayer­, Wolfgang C., James A. Tumlin, Steven Fishbane, et al.. (2021). MO539HEMATOLOGIC EFFICACY OF VADADUSTAT FOR ANEMIA IN PATIENTS WITH KIDNEY FAILURE ON DIALYSIS. Nephrology Dialysis Transplantation. 36(Supplement_1).
18.
Eckardt, Kai‐Uwe, Rajiv Agarwal, Youssef M.K. Farag, et al.. (2020). Global Phase 3 programme of vadadustat for treatment of anaemia of chronic kidney disease: rationale, study design and baseline characteristics of dialysis-dependent patients in the INNO2VATE trials. Nephrology Dialysis Transplantation. 36(11). 2039–2048. 20 indexed citations
19.
Nangaku, Masaomi, Youssef M.K. Farag, Emil M. deGoma, et al.. (2020). Vadadustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor, for treatment of anemia of chronic kidney disease: two randomized Phase 2 trials in Japanese patients. Nephrology Dialysis Transplantation. 36(7). 1244–1252. 33 indexed citations
20.
Mohamed, Amal Ahmed, et al.. (2019). Dose–response association between vitamin D deficiency and atopic dermatitis in children, and effect modification by gender: a case-control study. Journal of Dermatological Treatment. 32(2). 174–179. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tara DiMino Breakdown of academic impact, for papers by B. Ehmer Breakdown of academic impact, for papers by Karen L. Onions Breakdown of academic impact, for papers by Raashda A. Sulaiman Breakdown of academic impact, for papers by Magdalene M. George Breakdown of academic impact, for papers by Matthias Wörn Breakdown of academic impact, for papers by Shivinder Jolly Breakdown of academic impact, for papers by Ashley E. Benson Breakdown of academic impact, for papers by Frank Joseph Breakdown of academic impact, for papers by A Calafiore
Rankless by CCL
2026